Compare
Virgin Galactic Holdings, Inc vs MingZhu Logistics Holdings Ltd vs Strata Critical Medical, Inc. vs DocGo Inc.
| Latest fiscal year | Virgin Galactic Holdings, Inc SPCE | MingZhu Logistics Holdings Ltd YGMZFLast annual report: year ended 2024-12-31 | Strata Critical Medical, Inc. SRTA | DocGo Inc. DCGO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2024-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.54M | $40.43M | $197.14M | $322.20M |
| Revenue growth (YoY) | -78.1% | -54.6% | +34.3% | -47.7% |
| Gross margin | n/m (computed) | n/a | 20.9% | n/a |
| Operating margin | n/m | -10.0% | -11.3% | -55.3% |
| Net margin | n/m | -15.3% | 21.0% | -56.6% |
| Net income | -$278.91M | -$6.19M | $41.35M | -$182.40M |
| EPS (Diluted) | -$5.44 | -$1.31 | $0.50 | -$1.84 |
| Operating cash flow | -$240.14M | -$2.59M | -$48.91M | $34.45M |
| Free cash flow | -$438.19M | -$2.70M | -$58.51M | $29.91M |
| Cash & equivalents | $144.73M | $698.2K | $30.97M | $51.02M |
| Total assets | $803.18M | $90.33M | $325.47M | $217.10M |
| Total liabilities | $529.22M | $45.58M | $46.40M | $91.23M |
| Shareholders' equity | $273.96M | $44.75M | $279.07M | $144.01M |
| Return on year-end equity | -101.8% | -13.8% | 14.8% | -126.7% |
| Shares outstanding | 73.33M | 6.68M | n/a | 98.64M |
Revenue, most recent five fiscal years
| Fiscal year | Virgin Galactic Holdings, Inc | MingZhu Logistics Holdings Ltd | Strata Critical Medical, Inc. | DocGo Inc. |
|---|---|---|---|---|
| Latest | $1.54M Ended 2025-12-31 | $40.43M Ended 2024-12-31 | $197.14M Ended 2025-12-31 | $322.20M Ended 2025-12-31 |
| 1 year earlier | $7.04M Ended 2024-12-31 | $89.00M Ended 2023-12-31 | $146.82M Ended 2024-12-31 | $616.56M Ended 2024-12-31 |
| 2 years earlier | $6.80M Ended 2023-12-31 | $63.52M Ended 2022-12-31 | $225.18M Ended 2023-12-31 | $624.29M Ended 2023-12-31 |
| 3 years earlier | $2.31M Ended 2022-12-31 | $17.36M Ended 2021-12-31 | $146.12M Ended 2022-12-31 | $440.52M Ended 2022-12-31 |
| 4 years earlier | $3.29M Ended 2021-12-31 | $18.79M Ended 2020-12-31 | n/a | $318.72M Ended 2021-12-31 |